Filip M. Szymanski

Kazimierza Woycickiego 1 Street
Warsaw, MZ 01938, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 98 publications

Influence of antiviral treatment in hepatitis C patients on metabolism and fibrosis process.

Influence of antiviral treatment in hepatitis C patients on metabolism and fibrosis process.

Journal: Frontiers in medicine

Published: October 21, 2025

Recommendations for hypolipidemic and antithrombotic therapy in HCV-infected patients treated with direct-acting antiviral agents: expert position statement.

Recommendations for hypolipidemic and antithrombotic therapy in HCV-infected patients treated with direct-acting antiviral agents: expert position statement.

Journal: Clinical and experimental hepatology

Published: August 01, 2025

Practical aspects of antiplatelet therapy individualization among patients undergoing PCI for ACS and CCS. The joint expert opinion of the Working Group on Cardiovascular Pharmacotherapy and the Association of Cardiovascular Interventions of the Polish Cardiac Society.

Practical aspects of antiplatelet therapy individualization among patients undergoing PCI for ACS and CCS. The joint expert opinion of the Working Group on Cardiovascular Pharmacotherapy and the Association of Cardiovascular Interventions of the Polish Cardiac Society.

Journal: Kardiologia polska

Published: July 30, 2025

Interdisciplinary expert team statement on the treatment of multi-bed atherosclerotic disease - endorsed by Polish Cardiac Society, Polish Lipid Association, Polish Society of Diabetology, Polish Neurological Society, Polish Society of Nephrology.

Interdisciplinary expert team statement on the treatment of multi-bed atherosclerotic disease - endorsed by Polish Cardiac Society, Polish Lipid Association, Polish Society of Diabetology, Polish Neurological Society, Polish Society of Nephrology.

Journal: Kardiologia polska

Published: March 06, 2025

Treatment of dyslipidemia in Poland - common diagnostics, early combined therapy. Expert position statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. 5th Declaration of Sopot.

Treatment of dyslipidemia in Poland - common diagnostics, early combined therapy. Expert position statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. 5th Declaration of Sopot.

Journal: Cardiology journal

Published: November 21, 2024

Rosuvastatin-based combination treatment with acetylsalicylic acid or ezetimibe in the management of patients at high and very high cardiovascular risk. Expert opinion paper of the Polish Lipid Association 2025.

Rosuvastatin-based combination treatment with acetylsalicylic acid or ezetimibe in the management of patients at high and very high cardiovascular risk. Expert opinion paper of the Polish Lipid Association 2025.

Journal: Archives of medical science : AMS

Published: October 10, 2024

Post-COVID-19 syndrome in everyday clinical practice: interdisciplinary expert position statement endorsed by the Polish Society of Civilization Diseases.

Post-COVID-19 syndrome in everyday clinical practice: interdisciplinary expert position statement endorsed by the Polish Society of Civilization Diseases.

Journal: Polish archives of internal medicine

Published: April 15, 2024

Enhancing Patient Adherence to Newly-Prescribed Medicine for Chronic Diseases: A Comprehensive Review and Cost-Effective Approach to Implementing the New Medicine Service in Community Pharmacies in Poland.

Enhancing Patient Adherence to Newly-Prescribed Medicine for Chronic Diseases: A Comprehensive Review and Cost-Effective Approach to Implementing the New Medicine Service in Community Pharmacies in Poland.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: March 03, 2024

Pharmacotherapy of heart failure A.D. 2023. Expert opinion of Working Group on Cardiovascular Pharmacotherapy, Polish Cardiac Society.

Pharmacotherapy of heart failure A.D. 2023. Expert opinion of Working Group on Cardiovascular Pharmacotherapy, Polish Cardiac Society.

Journal: Kardiologia polska

Published: May 02, 2023

Metabolic associated fatty liver disease and cardiovascular risk: The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society.

Metabolic associated fatty liver disease and cardiovascular risk: The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society.

Journal: Kardiologia polska

Published: January 22, 2023

Rules for the use of reduced doses of non-vitamin K antagonist oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation. The opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society

Rules for the use of reduced doses of non-vitamin K antagonist oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation. The opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society

Journal: Kardiologia polska

Published: November 14, 2022

The use of GLP-1 analogues in the treatment of diabetes in patients with cardiovascular diseases. The expert opinion of the Working Group of Cardiovascular Pharmacotherapy of the Polish Cardiac Society.

The use of GLP-1 analogues in the treatment of diabetes in patients with cardiovascular diseases. The expert opinion of the Working Group of Cardiovascular Pharmacotherapy of the Polish Cardiac Society.

Journal: Kardiologia polska

Published: November 13, 2022

Showing 1-12 of 98

Last Updated: 09/26/2026